2023 | Large Institutional Experience of Early Outcomes and Dosimetric Findings with Postoperative Stereotactic Partial Breast Irradiation in Breast Cancer | RADIOTHERAPY AND ONCOLOGY |
2020 | Liver-directed combined radiotherapy as a bridge to curative surgery in locally advanced hepatocellular carcinoma beyond the Milan criteria | RADIOTHERAPY AND ONCOLOGY |
2009 | Low-dose craniospinal irradiation as a definitive treatment for intracranial germinoma | RADIOTHERAPY AND ONCOLOGY |
2022 | Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy | RADIOTHERAPY AND ONCOLOGY |
2018 | Mapping patterns of locoregional recurrence following contemporary treatment with radiation therapy for breast cancer: A multi-institutional validation study of the ESTRO consensus guideline on clinical target volume | RADIOTHERAPY AND ONCOLOGY |
2017 | Novel recursive partitioning analysis classification for newly diagnosed glioblastoma: A multi-institutional study highlighting the MGMT promoter methylation and IDH1 gene mutation status | RADIOTHERAPY AND ONCOLOGY |
2017 | Palliative radiation therapy in the last 30 days of life: A systematic review | RADIOTHERAPY AND ONCOLOGY |
2012 | Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: implications for postoperative radiotherapy | RADIOTHERAPY AND ONCOLOGY |
2008 | Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer | RADIOTHERAPY AND ONCOLOGY |
2010 | Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer | RADIOTHERAPY AND ONCOLOGY |
2019 | Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer | RADIOTHERAPY AND ONCOLOGY |
2020 | Postoperative radiotherapy for WHO grade II-III intracranial ependymoma in adults: An intergroup collaborative study (KROG 18-06/KNOG 18-01) | RADIOTHERAPY AND ONCOLOGY |
2019 | Practical effectiveness of re-irradiation with or without surgery for locoregional recurrence of rectal cancer: A meta-analysis and systematic review | RADIOTHERAPY AND ONCOLOGY |
2023 | Prognosis prediction for glioblastoma multiforme patients using machine learning approaches: Development of the clinically applicable model | RADIOTHERAPY AND ONCOLOGY |
2023 | Regional lymph node recurrence after stereotactic body radiation therapy for lung cancer: Patterns of recurrence, treatment approaches, and clinical outcomes (KROG 21-09) | RADIOTHERAPY AND ONCOLOGY |
2017 | Reply to the Letter to the Editor by Vargo et al | RADIOTHERAPY AND ONCOLOGY |
2019 | Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma | RADIOTHERAPY AND ONCOLOGY |
2023 | Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy | RADIOTHERAPY AND ONCOLOGY |
2020 | Significance of lymphocyte recovery from treatment-related lymphopenia in locally advanced pancreatic cancer | RADIOTHERAPY AND ONCOLOGY |
2022 | Significance of mid-radiotherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography in esophageal cancer | RADIOTHERAPY AND ONCOLOGY |
2017 | Three-dimensional analysis of patterns of locoregional recurrence after treatment in breast cancer patients: Validation of the ESTRO consensus guideline on target volume | RADIOTHERAPY AND ONCOLOGY |
2019 | Upfront chemotherapy followed by response adaptive radiotherapy for intracranial germinoma: Prospective multicenter cohort study | Radiotherapy and Oncology |
2018 | Validation of a novel molecular RPA classification in glioblastoma (GBM-molRPA) treated with chemoradiation: A multi-institutional collaborative study | RADIOTHERAPY AND ONCOLOGY |